Related Experiment Video
Updated: Jun 15, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Immunogen display on virus-like particles assembled from redesigned transcription activator-like effector proteins
Amanda P Gonçalves1, Robbert J de Haas2, Anésia A Santos1
1Department of General Biology, Federal University of Viçosa, Viçosa 36570-900, Minas Gerais, Brazil; National Institute of Science and Technology in Plant-Pest Interactions, Bioagro, Federal University of Viçosa, Viçosa 36570-900, Minas Gerais, Brazil; Laboratory of Applied Cancer Research, Biological Physics Section, Department of Physics, Federal University of Viçosa, Viçosa 36570-900, Minas Gerais, Brazil.
Abstract:
Virus-like particles (VLPs) assembled from designed proteins are considered for eliciting immune responses. While many of VLPs assembled from designed proteins are spherical and lack a nucleic acid cargo, we show that our recently designed artificial capsid protein NucleoX11 self-assembles around single double-stranded nucleic acid fragments, forming rod-shaped VLPs whose length can be easily determined depending on the size of the template nucleic acid. To explore these designed VLPs as a vaccine platform, we have successfully incorporated the SpyCatcher003 peptide into NucleoX11 protein sequence via genetic fusion, thereby enabling the decoration of self-assembled VLPs with SpyTagged antigens. We show that SpyCatcher003_NucleoX11 VLPs are stable in both decorated and undecorated versions, forming self-assembled rod-shaped VLPs when incubated with 250 bp double-stranded DNA or poly I:C double-stranded RNA fragments. The antigen-decorated VLPs are efficiently taken up by antigen-presenting cells (APCs) in a dose-dependent manner and enhance the expression of the immune activation markers CD80 and CD86 molecules, which are crucial for activating naïve antigen specific T cells. These results demonstrate the potential of our construct as a versatile platform for the production of size-customizable VLPs with clinical application, such novel vaccine platform or drug-delivery systems.
More Related Videos
11:58Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
05:15Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
Published on: February 10, 2022
Related Concept Videos
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...
Vaccinations